Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial

Affiliations

• ¹ Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
• ² Institute for Biostatistics, Hannover Medical School, Hannover, Germany.
• ³ Department for Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
• ⁴ Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
• ⁵ Department of Cardiology, Paracelsus Medical University, Nuremberg, Germany.
• ⁶ MVZ Kardiologie, Klinikum Neumarkt, Neumarkt, Germany.
• ⁷ Department of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany.
• ⁸ Department of Internal and Cardiovascular Medicine, Herzzentrum Dresden, University Clinic, Dresden, Technische Universität Dresden, Dresden, Germany.
• ⁹ Clinic for Internal Medicine, University Clinical Hospital Center Bezanijska Kosa, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
• ¹⁰ Universitätsklinik für Innere Medizin II, Abteilung Kardiologie, Medizinische Universität Wien, Wien, Austria.
• ¹¹ Center for Clinical Trials, Hannover Medical School, Hannover, Germany.
• ¹² German Centre for Cardiovascular Research, Partner Site North, Hamburg, Germany.
• ¹³ Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
• ¹⁴ Orgenesis, Inc, Germantown, USA.
• ¹⁵ Hannover Medical School, Germany.
• ¹⁶ Center for Electrophysiology Bremen, Bremen, Germany.
• ¹⁷ Department Clinical Research & Epidemiology, Comprehensive Heart Failure Center Würzburg, and Department Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
• ¹⁸ HOMICAREM (HOMburg Institute for CArdioREnalMetabolic Medicine), Medical Faculty, Campus Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany.